Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPOETIN ALFA-EPBX for Haemoglobin abnormal: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where EPOETIN ALFA-EPBX was used for Haemoglobin abnormal.

Most Reported Side Effects for EPOETIN ALFA-EPBX

Side Effect Reports % Deaths Hosp.
Death 329 24.5% 317 5
Off label use 263 19.6% 57 19
Haemoglobin decreased 112 8.4% 3 21
Hospitalisation 49 3.7% 0 44
Anaemia 42 3.1% 1 12
Asthenia 42 3.1% 2 6
Drug ineffective 41 3.1% 2 4
Product dose omission issue 39 2.9% 1 4
Fatigue 33 2.5% 0 5
Malaise 33 2.5% 0 4
Hypoacusis 30 2.2% 2 0
Dyspnoea 24 1.8% 2 14
Illness 24 1.8% 4 5
Haematocrit decreased 23 1.7% 0 4
Covid-19 21 1.6% 1 6

Other Indications for EPOETIN ALFA-EPBX

Anaemia (267) Nephrogenic anaemia (169) Chronic kidney disease (136) Myelodysplastic syndrome (69) Product used for unknown indication (48) Haemoglobin decreased (26) Anaemia of chronic disease (24) End stage renal disease (22) Iron deficiency anaemia (18) Myelofibrosis (16)

Other Drugs Used for Haemoglobin abnormal

DARBEPOETIN ALFA (19) ERYTHROPOIETIN (15) EXENATIDE (7) METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (6) FERRIC CARBOXYMALTOSE (5)

Related Pages

EPOETIN ALFA-EPBX Full Profile All Haemoglobin abnormal Drugs EPOETIN ALFA-EPBX Demographics EPOETIN ALFA-EPBX Timeline